Transcode Therapeutics (RNAZ) Other Non-Current Assets (2020 - 2025)
Transcode Therapeutics' (RNAZ) quarterly Other Non-Current Assets came in at $111856.0 in Q1 2025, little changed YoY from $111856.0 in Q1 2024, and little changed on a QoQ basis from $111856.0 in Q4 2024.
Transcode Therapeutics (RNAZ) Other Non-Current Assets (2020 - 2025) Analysis & Trends
Transcode Therapeutics (RNAZ) has 4 years of Other Non-Current Assets data on file, last reported at $111856.0 in Q1 2025.
- Quarterly Other Non-Current Assets changed 0.0% year-over-year to $111856.0 in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $111856.0 (changed 0.0% YoY) and the FY2024 annual result came in at $111856.0, changed 0.0% from the prior year.
- Other Non-Current Assets held at $111856.0 in Q1 2025, from $111856.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $111856.0 in Q1 2023 to a low of $111856.0 in Q1 2023.
- A 3-year average of $111856.0 and a median of $111856.0 in 2023 frame the typical range for Other Non-Current Assets.
- The widest YoY moves for Other Non-Current Assets: up 0.0% in 2024, down 0.0% in 2024.
- Tracing RNAZ's Other Non-Current Assets over 3 years: stood at $111856.0 in 2023, then changed by 0.0% to $111856.0 in 2024, then changed by 0.0% to $111856.0 in 2025.
- The last three Other Non-Current Assets figures came in at $111856.0 (Q1 2025), $111856.0 (Q4 2024), and $111856.0 (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 2.31 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 124.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 618.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 109.58 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 65.13 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 104.44 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 62.96 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 202.31 Mn |
| 10 | Transcode Therapeutics | 2.84 Mn | 2.84 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 111,856.00 |
| Dec 31, 2024 | 111,856.00 |
| Sep 30, 2024 | 111,856.00 |
| Jun 30, 2024 | 111,856.00 |
| Mar 31, 2024 | 111,856.00 |
| Dec 31, 2023 | 111,856.00 |
| Sep 30, 2023 | 111,856.00 |
| Jun 30, 2023 | 111,856.00 |
| Mar 31, 2023 | 111,856.00 |
| Dec 31, 2020 | 8,002.00 |